Data for: Rifamycin derivatives active against pathogenic rapidly-growing mycobacteria

2019-08-09T06:41:59Z (GMT) by Keith Combrink
MIC and Zone of inhibition data for a series of C25 Carbamate derivatives against a panel of clinical isolates of RGM including Mycobacterium abscessus